David Samuel Dicapua Siegel, MD

Dr. Siegel is one of the nation’s foremost authorities on multiple myeloma (a blood cancer). His research has almost exclusively focused on multiple myeloma, and AL amyloidosis. He has been involved as a lead investigator in clinical trials of several medications that have become standard care for multiple myeloma. Founding Director of the Multiple Myeloma Institute, he and his team collaborate with other scientists and clinical researchers to pioneer more effective therapies for patients with this challenging disease.